Cytokine Signature Allowing COVID-19 Patients with Worst Prognosis to Be Spotted Early Is Identified by Italian Researchers

New research being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal (April 23-26) has identified a panel of cytokines that can help predict which COVID-19 patients are at risk of serious illness and death. An overreaction of the immune system, in which excessive levels of proteins called cytokines produce damaging levels of inflammation, can lead to organ failure and death in COVID-19 patients. It isn’t known, however, which cytokines drive the process. Being able to measure levels of these cytokines when patients are admitted to the hospital would allow those with the worst prognosis to be identified and their therapy personalized.

Login Or Register To Read Full Story